Cargando…
Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666160/ https://www.ncbi.nlm.nih.gov/pubmed/33188166 http://dx.doi.org/10.1038/s41392-020-00394-2 |
| _version_ | 1783610080084623360 |
|---|---|
| author | Kang, Yuanbo He, Weihan Ren, Caiping Qiao, Jincheng Guo, Qiuyong Hu, Jingyu Xu, Hongjuan Jiang, Xingjun Wang, Lei |
| author_facet | Kang, Yuanbo He, Weihan Ren, Caiping Qiao, Jincheng Guo, Qiuyong Hu, Jingyu Xu, Hongjuan Jiang, Xingjun Wang, Lei |
| author_sort | Kang, Yuanbo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7666160 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Nature Publishing Group UK |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-76661602020-11-17 Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma Kang, Yuanbo He, Weihan Ren, Caiping Qiao, Jincheng Guo, Qiuyong Hu, Jingyu Xu, Hongjuan Jiang, Xingjun Wang, Lei Signal Transduct Target Ther Correction Nature Publishing Group UK 2020-11-13 /pmc/articles/PMC7666160/ /pubmed/33188166 http://dx.doi.org/10.1038/s41392-020-00394-2 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Kang, Yuanbo He, Weihan Ren, Caiping Qiao, Jincheng Guo, Qiuyong Hu, Jingyu Xu, Hongjuan Jiang, Xingjun Wang, Lei Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma |
| title | Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma |
| title_full | Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma |
| title_fullStr | Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma |
| title_full_unstemmed | Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma |
| title_short | Correction: Advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma |
| title_sort | correction: advances in targeted therapy mainly based on signal pathways for nasopharyngeal carcinoma |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666160/ https://www.ncbi.nlm.nih.gov/pubmed/33188166 http://dx.doi.org/10.1038/s41392-020-00394-2 |
| work_keys_str_mv | AT kangyuanbo correctionadvancesintargetedtherapymainlybasedonsignalpathwaysfornasopharyngealcarcinoma AT heweihan correctionadvancesintargetedtherapymainlybasedonsignalpathwaysfornasopharyngealcarcinoma AT rencaiping correctionadvancesintargetedtherapymainlybasedonsignalpathwaysfornasopharyngealcarcinoma AT qiaojincheng correctionadvancesintargetedtherapymainlybasedonsignalpathwaysfornasopharyngealcarcinoma AT guoqiuyong correctionadvancesintargetedtherapymainlybasedonsignalpathwaysfornasopharyngealcarcinoma AT hujingyu correctionadvancesintargetedtherapymainlybasedonsignalpathwaysfornasopharyngealcarcinoma AT xuhongjuan correctionadvancesintargetedtherapymainlybasedonsignalpathwaysfornasopharyngealcarcinoma AT jiangxingjun correctionadvancesintargetedtherapymainlybasedonsignalpathwaysfornasopharyngealcarcinoma AT wanglei correctionadvancesintargetedtherapymainlybasedonsignalpathwaysfornasopharyngealcarcinoma |